FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions refers to a method of treating diabetes and a composition for treating diabetes. Method of treating diabetes involves administering a composition containing combination of 5'-Methylseleno adenosine, Se-Adenosyl-L-homocysteine and Gamma-glutamyl-methylselenocysteine and a pharmaceutically acceptable carrier, taken in certain concentrations. Composition for treating diabetes contains combination of 5'-Methylseleno adenosine, Se-Adenosyl-L-homocysteine and Gamma-glutamyl-methylselenocysteine and a pharmaceutically acceptable carrier, taken in certain concentrations.
EFFECT: group of inventions provides a combination of selenium compounds effective as insulin-replacement therapy and as an insulin-enhancing agent for treating type I or type II diabetes.
9 cl, 38 dwg, 1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS OF ORGANOSELENIUM COMPOUNDS AND METHODS OF THEIR APPLICATION | 2014 |
|
RU2665135C2 |
| PHARMACEUTICAL AGENTS, COMPOSITIONS, AND METHODS RELATED THERETO | 2018 |
|
RU2765286C2 |
| OBESITY TREATMENT | 2019 |
|
RU2822679C2 |
| COMBINATED INHIBITORS OF FBP-ASE AND ANTIDIABETIC AGENTS FOR DIABETES TREATMENT | 2001 |
|
RU2328308C2 |
| INHIBITORS - AMINO - CARBOXYMUCONATE - SEMIALDEHYDE - DECARBOXYLASE | 2015 |
|
RU2746405C2 |
| OLIGONUCLEOTIDE SEQUENCES AIMED AT THE TRANSCRIPTION FACTOR TSC22D4, FOR TREATING INSULIN RESISTANCE | 2016 |
|
RU2723091C2 |
| TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2019 |
|
RU2815647C2 |
| THIAZOLIDINEDIONE ANALOGUES | 2007 |
|
RU2445957C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2513636C2 |
| NOVEL COMPOUNDS WITH SPIROCHIRAL CARBON BASE, METHODS OF THEIR OBTAINING AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN SUCH COMPOUNDS | 2009 |
|
RU2492173C2 |
